Fulcrum Therapeutics Inc (FULC)

Jun 12, 2025

Bank of America Corp DE Has $432,000 Stock Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jun 12, 2025

Jun 12, 2025

Research Analysts Issue Forecasts for FULC FY2026 Earnings - Defense World

Jun 12, 2025

Jun 11, 2025

Citadel Advisors LLC Makes New $69,000 Investment in Lisata Therapeutics, Inc. (NASDAQ:LSTA) - Defense World

Jun 11, 2025

Jun 11, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Millennium Management LLC - Defense World

Jun 11, 2025

Jun 10, 2025

Comparing Fulcrum Therapeutics (NASDAQ:FULC) and Lakeshore Biopharma (NASDAQ:LSB) - Defense World

Jun 10, 2025

Jun 08, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Two Sigma Investments LP - Defense World

Jun 08, 2025

Jun 08, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jun 08, 2025

Jun 06, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FULC Stock News - GuruFocus

Jun 06, 2025

Jun 06, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule - MarketScreener

Jun 06, 2025

Jun 06, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025

Jun 06, 2025

Fulcrum Therapeutics Awards Major Stock Options Package: 70,000 Shares at $6.96 Exercise Price - Stock Titan

Jun 06, 2025

Jun 06, 2025

Fulcrum Therapeutics, Inc. (FULC): A Bull Case Theory - MSN

Jun 06, 2025

Jun 05, 2025

BNP Paribas Financial Markets Makes New Investment in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jun 05, 2025

May 30, 2025

Fulcrum Therapeutics (NASDAQ:FULC) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st

May 30, 2025

May 29, 2025

Fulcrum Therapeutics to Present at Upcoming Medical Meetings | FULC Stock News - GuruFocus

May 29, 2025

May 29, 2025

Fulcrum Therapeutics to Present at Upcoming Medical Meetings - Eagle-Tribune

May 29, 2025

May 29, 2025

New Oral Sickle Cell Drug Shows Promise: Fulcrum to Reveal Phase 1 Trial Results at Global Medical Conferences - Stock Titan

May 29, 2025

May 29, 2025

Fulcrum Therapeutics to Participate in the 46th Annual Goldman S - GuruFocus

May 29, 2025

May 29, 2025

Fulcrum Therapeutics (FULC) Target Price Raised Amid Key Data An - GuruFocus

May 29, 2025

May 29, 2025

FULC: Piper Sandler Raises Price Target for Fulcrum Therapeutics | FULC Stock News - GuruFocus

May 29, 2025

May 29, 2025

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference | FULC Stock News - GuruFocus

May 29, 2025

May 29, 2025

Rare Disease Innovator Fulcrum Therapeutics Takes Stage at Elite Goldman Sachs Healthcare Conference - Stock Titan

May 29, 2025

May 27, 2025

Fulcrum gains as Leerink upgrades ahead of data for lead asset - MSN

May 27, 2025

May 26, 2025

Fulcrum Therapeutics (NASDAQ:FULC) Upgraded at Leerink Partners - Defense World

May 26, 2025

May 25, 2025

Leerink Partnrs Upgrades Fulcrum Therapeutics (NASDAQ:FULC) to Strong-Buy - Defense World

May 25, 2025

May 24, 2025

Leerink raises Fulcrum Therapeutics stock to Outperform By Investing.com - Investing.com Canada

May 24, 2025

May 24, 2025

Northern Trust Corp Buys 142,578 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

May 24, 2025

May 23, 2025

Fulcrum Therapeutics Shares Rise After Upgrade From Leerink - marketscreener.com

May 23, 2025

May 23, 2025

Fulcrum stock gains as Leerink upgrades (FULC:NASDAQ) - Seeking Alpha

May 23, 2025

May 23, 2025

Fulcrum Therapeutics (FULC) Receives Analyst Upgrade and Increas - GuruFocus

May 23, 2025

May 23, 2025

Leerink Partners Upgrades Fulcrum Therapeutics (FULC) - Nasdaq

May 23, 2025

May 23, 2025

Leerink Upgrades Fulcrum Therapeutics to Outperform From Market Perform, Adjusts Price Target to $12 From $4 - marketscreener.com

May 23, 2025

May 23, 2025

Fulcrum Therapeutics (FULC) Receives Analyst Upgrade on Positive Outlook | FULC Stock News - GuruFocus

May 23, 2025

May 21, 2025

Fulcrum Therapeutics at RBC Capital: Strategic Steps in Sickle Cell Treatment - Investing.com Canada

May 21, 2025

May 18, 2025

Cantor Fitzgerald Predicts FULC FY2025 Earnings - Defense World

May 18, 2025

May 17, 2025

Price T Rowe Associates Inc. MD Raises Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

May 17, 2025

May 17, 2025

Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Upgraded by Cantor Fitzgerald - Defense World

May 17, 2025

May 17, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives $6.67 Average Price Target from Analysts - Defense World

May 17, 2025

May 15, 2025

Cantor Fitzgerald Upgrades Fulcrum Therapeutics (FULC) - Nasdaq

May 15, 2025

May 15, 2025

Fulcrum Therapeutics Shares Rise After Cantor Fitzgerald Upgrade - marketscreener.com

May 15, 2025

May 15, 2025

Fulcrum Therapeutics (FULC) Upgraded to Overweight by Cantor Fit - GuruFocus

May 15, 2025

May 15, 2025

Cantor Fitzgerald Upgrades Fulcrum Therapeutics to Overweight From Neutral, Price Target is $10 - marketscreener.com

May 15, 2025

May 15, 2025

FULC Stock Upgraded to Overweight by Cantor Fitzgerald with $10 - GuruFocus

May 15, 2025

May 15, 2025

FULC Stock Upgraded to Overweight by Cantor Fitzgerald with $10 Target | FULC Stock News - GuruFocus

May 15, 2025

May 14, 2025

Fulcrum Therapeutics (FULC) Upgraded by Cantor Fitzgerald with P - GuruFocus

May 14, 2025

May 14, 2025

Fulcrum Therapeutics (FULC) Upgraded by Cantor Fitzgerald with Positive Outlook | FULC Stock News - GuruFocus

May 14, 2025

May 12, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Dimensional Fund Advisors LP - Defense World

May 12, 2025

May 10, 2025

Wells Fargo & Company MN Has $161,000 Stake in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

May 10, 2025

May 10, 2025

Fulcrum Therapeutics (FULC) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025